A. Irvine

发表

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey

C. Flohr, H. Audrain, H. Shahidullah, 2016, The British journal of dermatology.

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

C. Flohr, A. Paller, G. Girolomoni, 2019, The British journal of dermatology.

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

C. Flohr, A. Paller, J. Thyssen, 2018, The British journal of dermatology.

Mucocutaneous sarcoidosis treated with mycophenolate mofetil

A. Paller, A. Irvine, C. Sitaru, 2002, The British journal of dermatology.

The molecular genetics of the genodermatoses: progress to date and future directions

A. Irvine, W. McLean, A. Irvine, 2003, The British journal of dermatology.

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) in the Irish Population

N. Murphy, A. Irvine, I. Ulmanen, 2006, Journal of pediatric endocrinology & metabolism : JPEM.

Wide spectrum of filaggrin‐null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations

M. Tang, J. Common, H. Cordell, 2011, The British journal of dermatology.

Carney complex: report of a kindred with predominantly cutaneous manifestations

M. Walsh, D. Armstrong, J. Handley, 1997, The British journal of dermatology.

Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor

S. Langabeer, A. Irvine, S. McCarron, 2014, The British journal of dermatology.

Dermatological manifestations of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome

A. Irvine, T. Ilmarinen, M. Dominguez, 2006, The British journal of dermatology.

Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype–genotype correlation

A D Irvine, W H McLean, A. D. Irvine, 1999, The British journal of dermatology.

MicroRNA analysis of childhood atopic dermatitis reveals a role for miR‐451a *

S. Kežić, E. Kenny, M. McAleer, 2020, The British journal of dermatology.

Model-based meta-analysis to optimise S. aureus-targeted therapies for atopic dermatitis

R. Tanaka, T. Miyano, A. Irvine, 2021, medRxiv.

The effects of systemic immunomodulatory treatments on COVID‐19 outcomes in patients with atopic dermatitis: results from the global SECURE‐AD registry

E. Freeman, C. Flohr, E. Haufe, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir

C. Keohane, O. Smith, C. L. Bacon, 2011, Pediatric transplantation.

Dermatological presentation of disease associated with antineutrophil cytoplasmic antibodies: a report of two contrasting cases and a review of the literature

I. Bruce, A. Irvine, M. Walsh, 1996, The British journal of dermatology.

Miliary Neonatal Hemangiomatosis with Fulminant Heart Failure and Cardiac Septal Hypertrophy in Two Infants

A. Sands, F. Casey, A. O'Hagan, 2004, Pediatric dermatology.

Clinical examination for hyperlinear palms to determine filaggrin genotype: A diagnostic test accuracy study

K. Thomas, J. Chalmers, H. Williams, 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema*

C. Flohr, J. Schmitt, K. Logan, 2020, The British journal of dermatology.

Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide

A. Irvine, P. Mina-Osorio, A. D. Irvine, 2019, The British journal of dermatology.

Lipoatrophic panniculitis of the ankles

M. McDermott, A. Irvine, A. Madasseri, 2006, Clinical and experimental dermatology.

Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

C. Flohr, P. Di Meglio, N. Dand, 2020, The British journal of dermatology.

What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review†

C. Flohr, M. Page, R. Weller, 2019, The British journal of dermatology.

Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene

G. Melino, A. Terrinoni, A. Irvine, 2004, The British journal of dermatology.

The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients

A. Irvine, B. Kirby, S. Field, 2009, The British journal of dermatology.

A novel mutation in the 2B domain of keratin 2e causing ichthyosis bullosa of Siemens

H. Williams, A. Irvine, F. Smith, 2000, Clinical and experimental dermatology.

PS03 (P39): Real‐world disease characteristics and treatment patterns in patients with atopic dermatitis in the UK: results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey

P. Lepping, A. Pink, P. Longhurst, 2021, British Journal of Dermatology.

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement

J. Silverberg, R. Bissonnette, E. Guttman‐Yassky, 2019 .